Keros Therapeutics Total Assets 2020-2021 | KROS

Keros Therapeutics total assets from 2020 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Keros Therapeutics Annual Total Assets
(Millions of US $)
2020 $269
2019 $11
Keros Therapeutics Quarterly Total Assets
(Millions of US $)
2021-03-31 $258
2020-12-31 $269
2020-09-30 $138
2020-06-30 $150
2020-03-31 $61
2019-12-31 $11
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.224B $0.010B
Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel treatments for hematological and musculoskeletal disorders. The company's product pipeline consists of KER-050, KER-047and KER-012 which are in clinical stage. Keros Therapeutics, Inc. is based in LEXINGTON, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.471B 10.43
Amgen (AMGN) United States $140.559B 15.17
CSL (CSLLY) Australia $104.678B 0.00
Moderna (MRNA) United States $87.132B 173.60
Gilead Sciences (GILD) United States $86.902B 9.25
Illumina (ILMN) United States $65.798B 94.88
Biogen (BIIB) United States $62.437B 14.29
BioNTech SE (BNTX) Germany $57.922B 42.00
Regeneron Pharmaceuticals (REGN) United States $56.686B 16.23
Vertex Pharmaceuticals (VRTX) United States $56.114B 23.11
Alexion Pharmaceuticals (ALXN) United States $40.223B 15.28
BeiGene (BGNE) Cayman Islands $32.408B 0.00
Seagen (SGEN) United States $28.760B 49.68
Genmab (GMAB) Denmark $28.630B 33.56
Genmab (GNMSF) Denmark $25.912B 5.96
Horizon Therapeutics Public (HZNP) Ireland $21.117B 27.00
Exact Sciences (EXAS) United States $20.914B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.582B 0.00
CureVac (CVAC) Germany $19.775B 0.00
Incyte (INCY) United States $19.250B 38.06
Alnylam Pharmaceuticals (ALNY) United States $19.190B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $16.949B 89.12
Zai Lab (ZLAB) China $16.404B 0.00
ARGENX SE-ADR (ARGX) Netherlands $15.848B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.290B 139.45
Novavax (NVAX) United States $15.185B 0.00
Guardant Health (GH) United States $12.184B 0.00
QIAGEN (QGEN) Netherlands $10.879B 19.32
Repligen (RGEN) United States $10.432B 94.06
CRISPR Therapeutics AG (CRSP) Switzerland $9.373B 0.00
Denali Therapeutics (DNLI) United States $8.994B 322.65
Mirati Therapeutics (MRTX) United States $8.728B 0.00
Fate Therapeutics (FATE) United States $8.315B 0.00
Acceleron Pharma (XLRN) United States $7.944B 0.00
Exelixis (EXEL) United States $7.192B 114.75
Sarepta Therapeutics (SRPT) United States $6.920B 0.00
Ascendis Pharma (ASND) Denmark $6.902B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.733B 0.00
AbCellera Biologics (ABCL) $6.730B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.705B 0.00
Vir Biotechnology (VIR) United States $6.038B 0.00
Halozyme Therapeutics (HALO) United States $5.940B 32.59
SWEDISH ORP BIO (BIOVF) Sweden $5.677B 20.57
Intellia Therapeutics (NTLA) United States $5.667B 0.00
Beam Therapeutics (BEAM) United States $5.501B 0.00
Legend Biotech (LEGN) United States $5.465B 0.00
Twist Bioscience (TWST) United States $5.460B 0.00
Adaptive Biotechnologies (ADPT) United States $5.321B 0.00
I-Mab (IMAB) China $5.309B 0.00
Reata Pharmaceuticals (RETA) United States $5.297B 0.00
Galapagos (GLPG) Belgium $5.285B 0.00
NeoGenomics (NEO) United States $5.056B 857.40
Blueprint Medicines (BPMC) United States $4.907B 14.94
Apellis Pharmaceuticals (APLS) United States $4.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.373B 0.00
Certara (CERT) United States $4.155B 0.00
SpringWorks Therapeutics (SWTX) United States $4.120B 0.00
Arvinas (ARVN) United States $4.055B 0.00
Alkermes (ALKS) Ireland $4.035B 0.00
Arena Pharmaceuticals (ARNA) United States $3.925B 0.00
Intra-Cellular Therapies (ITCI) United States $3.518B 0.00
Emergent Biosolutions (EBS) United States $3.509B 6.99
Berkeley Lights (BLI) United States $3.155B 0.00
Insmed (INSM) United States $3.009B 0.00
Amicus Therapeutics (FOLD) United States $2.850B 0.00
MorphoSys AG (MOR) Germany $2.830B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.815B 0.00
Vericel (VCEL) United States $2.673B 720.75
Global Blood Therapeutics (GBT) United States $2.595B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.581B 0.00
Sorrento Therapeutics (SRNE) United States $2.509B 0.00
Editas Medicine (EDIT) United States $2.503B 0.00
ALX Oncology Holdings (ALXO) United States $2.455B 0.00
Kymera Therapeutics (KYMR) United States $2.339B 0.00
Bluebird Bio (BLUE) United States $2.286B 0.00
Myriad Genetics (MYGN) United States $2.258B 0.00
Myovant Sciences (MYOV) United Kingdom $2.184B 0.00
Morphic Holding (MORF) United States $2.176B 0.00
Instil Bio (TIL) United States $2.156B 0.00
Heska (HSKA) United States $2.148B 936.59
Revance Therapeutics (RVNC) United States $2.133B 0.00
Bionano Genomics (BNGO) United States $2.130B 0.00
Atea Pharmaceuticals (AVIR) United States $2.075B 0.00
Seer (SEER) $2.071B 0.00
Ligand Pharmaceuticals (LGND) United States $2.012B 33.66
Deciphera Pharmaceuticals (DCPH) United States $1.986B 0.00
Prothena (PRTA) Ireland $1.967B 0.00
Amarin (AMRN) Ireland $1.926B 0.00
Inovio Pharmaceuticals (INO) United States $1.916B 0.00
Seres Therapeutics (MCRB) United States $1.878B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.857B 0.00
C4 Therapeutics (CCCC) United States $1.814B 0.00
Castle Biosciences (CSTL) United States $1.785B 0.00
Arcus Biosciences (RCUS) United States $1.766B 0.00
Zymeworks (ZYME) Canada $1.735B 0.00
Genetron Holdings (GTH) China $1.719B 0.00
BioAtla (BCAB) United States $1.717B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.714B 0.00
Sangamo Therapeutics (SGMO) United States $1.692B 0.00
UniQure (QURE) Netherlands $1.687B 0.00
PureTech Health (PRTC) United States $1.651B 0.00
PHARMA MAR SA (PHMMF) Spain $1.635B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.635B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Alector (ALEC) United States $1.548B 0.00
Cytokinetics (CYTK) United States $1.544B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.531B 0.00
Protagonist Therapeutics (PTGX) United States $1.487B 0.00
Precigen (PGEN) United States $1.443B 0.00
Codexis (CDXS) United States $1.410B 0.00
NGM Biopharmaceuticals (NGM) United States $1.396B 0.00
Zealand Pharma (ZEAL) Denmark $1.383B 0.00
Avid Bioservices (CDMO) United States $1.381B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.329B 0.00
Northwest Biotherapeutics (NWBO) United States $1.327B 0.00
Ocugen (OCGN) United States $1.326B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.312B 0.00
Nurix Therapeutics (NRIX) United States $1.296B 0.00
Repare Therapeutics (RPTX) Canada $1.254B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.245B 0.00
Shattuck Labs (STTK) United States $1.213B 0.00
Celldex Therapeutics (CLDX) United States $1.211B 0.00
MiMedx (MDXG) United States $1.204B 0.00
Zealand Pharma (ZLDPF) Denmark $1.167B 0.00
Curis (CRIS) United States $1.161B 0.00
Agenus (AGEN) United States $1.141B 0.00
Pliant Therapeutics (PLRX) United States $1.134B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.067B 33.70
Dynavax Technologies (DVAX) United States $1.065B 0.00
Coherus BioSciences (CHRS) United States $1.062B 0.00
VBI Vaccines (VBIV) United States $1.045B 0.00
Mersana Therapeutics (MRSN) United States $1.043B 0.00
Mesoblast (MESO) Australia $1.034B 0.00
Scholar Rock Holding (SRRK) United States $1.022B 0.00
MannKind (MNKD) United States $1.004B 0.00
Avidity Biosciences (RNA) United States $0.950B 0.00
G1 THERAPEUTICS (GTHX) United States $0.922B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.917B 0.00
Cel-Sci (CVM) United States $0.911B 0.00
Merus (MRUS) Netherlands $0.907B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.894B 0.00
Inhibrx (INBX) United States $0.893B 0.00
Travere Therapeutics (TVTX) United States $0.883B 0.00
Sutro Biopharma (STRO) United States $0.867B 0.00
Epizyme (EPZM) United States $0.865B 0.00
Prometheus Biosciences (RXDX) United States $0.826B 0.00
Nkarta (NKTX) United States $0.826B 0.00
Affimed (AFMD) Germany $0.806B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.778B 0.00
Pharming Group (PHAR) Netherlands $0.771B 0.00
Verastem (VSTM) United States $0.756B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
SESEN BIO, INC (SESN) United States $0.724B 0.00
Kadmon Holdings (KDMN) United States $0.724B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.723B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.713B 0.00
IDEAYA Biosciences (IDYA) United States $0.713B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.711B 0.00
Clene (CLNN) United States $0.706B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.699B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Cara Therapeutics (CARA) United States $0.694B 60.26
ChromaDex (CDXC) United States $0.681B 0.00
Precision BioSciences (DTIL) United States $0.675B 0.00
AnaptysBio (ANAB) United States $0.668B 0.00
MeiraGTx Holdings (MGTX) United States $0.659B 0.00
DBV Technologies S.A (DBVT) France $0.655B 0.00
Anika Therapeutics (ANIK) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Orchard Therapeutics (ORTX) United Kingdom $0.641B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.630B 0.00
ALBIREO PHARMA (ALBO) United States $0.627B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.625B 0.00
Clovis Oncology (CLVS) United States $0.624B 0.00
Bolt Biotherapeutics (BOLT) United States $0.605B 0.00
Adagene (ADAG) China $0.598B 0.00
Codiak BioSciences (CDAK) United States $0.590B 0.00
Compugen (CGEN) Israel $0.571B 0.00
Inventiva S.A (IVA) France $0.566B 0.00
Selecta Biosciences (SELB) United States $0.561B 0.00
Forte Biosciences (FBRX) United States $0.554B 0.00
AC Immune SA (ACIU) Switzerland $0.524B 0.00
Starpharma Holdings (SPHRY) Australia $0.519B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.517B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.513B 0.00
XBiotech (XBIT) United States $0.512B 0.00
Gritstone Bio (GRTS) United States $0.502B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.483B 0.00
Geron (GERN) United States $0.475B 0.00
Athenex (ATNX) United States $0.472B 0.00
CytomX Therapeutics (CTMX) United States $0.469B 0.00
Spero Therapeutics (SPRO) United States $0.468B 0.00
RAPT THERAPTICS (RAPT) United States $0.467B 0.00
Puma Biotechnology (PBYI) United States $0.460B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.456B 0.00
Neoleukin Therapeutics (NLTX) United States $0.450B 0.00
Oncobiologics (OTLK) United States $0.446B 0.00
BeyondSpring (BYSI) United States $0.445B 0.00
AquaBounty Technologies (AQB) United States $0.440B 0.00
ANI Pharmaceuticals (ANIP) United States $0.435B 12.02
Cue Biopharma (CUE) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
Fortress Biotech (FBIO) United States $0.418B 0.00
Kala Pharmaceuticals (KALA) United States $0.412B 0.00
Angion Biomedica (ANGN) United States $0.403B 0.00
Opthea (OPT) Australia $0.389B 0.00
Adicet Bio (ACET) United States $0.379B 0.00
SQZ Biotechnologies (SQZ) United States $0.376B 0.00
WAVE Life Sciences (WVE) Singapore $0.372B 0.00
Syros Pharmaceuticals (SYRS) United States $0.364B 0.00
UROGEN PHARMA (URGN) United States $0.362B 0.00
BioDelivery Sciences (BDSI) United States $0.362B 14.68
Athersys (ATHX) United States $0.360B 0.00
Adverum Biotechnologies (ADVM) United States $0.358B 0.00
XOMA (XOMA) United States $0.345B 161.10
IBio (IBIO) United States $0.344B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.338B 0.00
Trevena (TRVN) United States $0.334B 0.00
Theratechnologies (THTX) Canada $0.333B 0.00
Frequency Therapeutics (FREQ) United States $0.331B 0.00
Innate Pharma S.A (IPHA) France $0.326B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.321B 0.00
Arbutus Biopharma (ABUS) United States $0.320B 0.00
Kaleido Biosciences (KLDO) $0.314B 0.00
CorMedix Inc (CRMD) United States $0.309B 0.00
Cogent Biosciences (COGT) United States $0.307B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
Cardiff Oncology (CRDF) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
Fulcrum Therapeutics (FULC) United States $0.295B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Bellus Health (BLU) Canada $0.274B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.274B 0.00
Talis Biomedical (TLIS) United States $0.266B 0.00
Kamada (KMDA) Israel $0.265B 18.03
Seelos Therapeutics (SEEL) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.261B 0.00
INmune Bio (INMB) United States $0.256B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.248B 0.00
Chiasma (CHMA) United States $0.241B 0.00
Checkpoint Therapeutics (CKPT) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
NextCure (NXTC) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.227B 0.00
X4 Pharmaceuticals (XFOR) United States $0.223B 0.00
Aptinyx (APTX) United States $0.219B 0.00
VTv Therapeutics (VTVT) United States $0.217B 0.00
OSMOTICA PHARM (OSMT) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Biofrontera AG (BFRA) Germany $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.193B 0.00
Synlogic (SYBX) United States $0.192B 0.00
TELA Bio (TELA) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
VolitionRX (VNRX) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.183B 4.70
Applied Genetic Technologies (AGTC) United States $0.183B 0.00
ObsEva SA (OBSV) Switzerland $0.181B 0.00
Clearside Biomedical (CLSD) United States $0.179B 0.00
Nicox SA (NICXF) France $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.170B 0.00
Galena Biopharma (SLS) United States $0.170B 0.00
Antibe Therapeutics (ATBPF) Canada $0.164B 0.00
Enzo Biochem (ENZ) United States $0.164B 48.57
Yumanity Therapeutics (YMTX) United States $0.162B 0.00
Eton Pharmaceuticals (ETON) United States $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.156B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Exicure (XCUR) United States $0.153B 0.00
Liminal BioSciences (LMNL) Canada $0.144B 0.00
Catalyst Biosciences (CBIO) United States $0.143B 0.00
Liquidia Technologies (LQDA) United States $0.143B 0.00
Cyclerion Therapeutics (CYCN) United States $0.142B 0.00
Palatin Technologies (PTN) United States $0.141B 0.00
Eyenovia (EYEN) United States $0.140B 0.00
Pluristem Therapeutics (PSTI) Israel $0.137B 0.00
Orgenesis (ORGS) United States $0.136B 278.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.136B 0.00
Erytech Pharma SA (ERYP) France $0.136B 0.00
Novogen (KZIA) Australia $0.134B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.134B 0.00
Aytu BioPharma (AYTU) United States $0.134B 0.00
ABVC BioPharma (ABVC) United States $0.128B 0.00
Longeveron (LGVN) United States $0.126B 0.00
Vascular Biogenics (VBLT) Israel $0.123B 0.00
Cocrystal Pharma (COCP) United States $0.121B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.117B 0.00
Aptevo Therapeutics (APVO) United States $0.114B 0.00
CytRx (CYTR) United States $0.113B 0.00
Celsion (CLSN) United States $0.113B 0.00
Vyant Bio (VYNT) United States $0.110B 0.00
ARAVIVE, INC (ARAV) United States $0.108B 0.00
Evofem Biosciences (EVFM) United States $0.108B 0.00
Beyond Air (XAIR) United States $0.108B 0.00
Armata Pharmaceuticals (ARMP) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.104B 0.00
Dyadic (DYAI) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
Zosano Pharma (ZSAN) United States $0.099B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.097B 0.00
AIkido Pharma (AIKI) United States $0.096B 0.00
Protalix BioTherapeutics (PLX) Israel $0.095B 0.00
Evogene (EVGN) Israel $0.095B 0.00
Lumos Pharma (LUMO) United States $0.093B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.092B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
Celyad SA (CYAD) Belgium $0.085B 0.00
Cleveland BioLabs (CBLI) United States $0.085B 0.00
ARIDIS PHARMACT (ARDS) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
Edesa Biotech (EDSA) Canada $0.077B 0.00
ATyr Pharma (LIFE) United States $0.077B 0.00
BioCardia (BCDA) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.073B 0.00
Advaxis (ADXS) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Cyclo Therapeutics (CYTH) United States $0.064B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.064B 0.00
AEterna Zentaris (AEZS) United States $0.064B 0.00
Viridian Therapeutics (VRDN) United States $0.063B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Windtree Therapeutics (WINT) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
AnPac Bio-Medical Science (ANPC) China $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.052B 0.00
Invo BioScience (INVO) United States $0.050B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Timber Pharmaceuticals (TMBR) United States $0.047B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Benitec Biopharma (BNTC) United States $0.038B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.87
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00